Closed System Transfer Devices for Drug Preparation
April 2011 : State of Pharmacy Compounding - Vol. 8 No. 4 - Page #14

Recognizing the safety risks in hazardous drug transfer, 44% of facilities have incorporated closed system transfer devices (CSTDs) into the compounding process. Those who have not adopted CSTDs cited budget constraints as the most common reason for not doing so. 

For more information on closed system transfer devices, visit www.pppmag.com/info and click on Closed System Transfer Devices.

To read the full article, please log in or register.

Current Issue

Our mission is to provide health system professionals with information to streamline operations and promote patient safety.

As a requester to PP&P you will receive all monthly issues, as well as our annual Resource Guide of product and service providers and all of our timely supplements on hot-button issues.

Thank you for reading PP&P, and we look forward to providing you with information to enhance the field.